tradingkey.logo
搜索

TELA Bio Inc

TELA
添加自选
0.699USD
+0.022+3.20%
交易中 美东报价延迟15分钟
31.30M总市值
亏损市盈率 TTM

关于 TELA Bio Inc 公司

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc简介

公司代码TELA
公司名称TELA Bio Inc
上市日期Nov 08, 2019
CEOKoblish (Antony)
员工数量209
证券类型Ordinary Share
年结日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编19355
电话14843202930
网址https://www.telabio.com/
公司代码TELA
上市日期Nov 08, 2019
CEOKoblish (Antony)

TELA Bio Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
18.47K
+23.01%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
18.47K
+23.01%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
18.47K
+23.01%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.68K
--
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
18.47K
+23.01%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
18.47K
+23.01%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
18.47K
+23.01%

常见问题

TELA Bio Inc的前五大股东是谁?

TELA Bio Inc 的前五大股东如下:Mr. Antony Koblish

有多少机构持有TELA Bio Inc(TELA)的股份?

截至2026Q1,共有163家机构持有TELA Bio Inc的股份,合计持有的股份价值约为32.85M,占公司总股份的73.39%。与2025Q4相比,机构持股有所增加,增幅为-6147477.00。

哪个业务部门对TELA Bio Inc的收入贡献最大?

在2026Q1,OviTex业务部门对TELA Bio Inc的收入贡献最大,创收51.22M,占总收入的63.81%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有